US CDC panel recommends Sanofi-AstraZeneca’s preventive RSV therapy for babies
By Syndicated ContentAug 3, 2023 | 3:39 PM
(Corrects to says ‘panel recommends’, not ‘CDC approves’, in headline, paragraph 1)
(Reuters) -The U.S. Centers for Disease Control and Prevention said its advisory committee on Thursday recommended use of Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (616) 392-3121.